CA Stock MarketDetailed Quotes
GTTX GeneTether Therapeutics Inc
- 0.020
- 0.0000.00%
15min DelayTrading Nov 14 09:30 ET
774.89KMarket Cap-1428P/E (TTM)
0.020High0.020Low24.00KVolume0.020Open0.020Pre Close480.00Turnover0.05552wk High0.28%Turnover Ratio38.74MShares0.01552wk Low-0.014EPS TTM174.26KFloat Cap0.680Historical HighLossP/E (Static)8.71MShs Float0.005Historical Low-0.013EPS LYR0.00%Amplitude--Dividend TTM0.51P/B1Lot Size--Div YieldTTM
GeneTether Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 29.77%-209.31K | 20.14%-78.67K | 60.53%-464.86K | 89.07%-26.24K | 81.12%-42.11K | 52.96%-298.01K | -21.15%-98.5K | -59.10%-1.18M | 35.79%-239.94K | 2.43%-223.01K |
| Net income from continuing operations | 23.13%-107.79K | 29.42%-144.22K | 59.87%-688.36K | 16.23%-316.22K | 93.13%-27.58K | 69.29%-140.22K | 57.40%-204.34K | -4.74%-1.72M | 32.71%-377.47K | 7.29%-401.49K |
| Operating gains losses | -129.15%-144 | -40.45%212 | -336.53%-6.76K | -1,340.16%-7.32K | -125.86%-294 | 1,108.16%494 | -84.37%356 | 917.08%2.86K | ---508 | --1.14K |
| Remuneration paid in stock | -93.46%2.03K | 107.72%3.3K | -71.23%177.87K | 228.75%244.49K | -153.59%-55K | -77.92%31.06K | -114.20%-42.68K | -29.38%618.3K | -62.36%74.37K | -47.46%102.63K |
| Change In working capital | 45.39%-103.41K | -58.12%62.05K | 162.61%52.4K | -17.05%52.81K | -45.45%40.76K | 40.36%-189.34K | 55.27%148.16K | -487.80%-83.68K | 703.54%63.67K | 716.11%74.72K |
| -Change in prepaid assets | 44.74%-71.77K | -66.70%45.78K | 168.17%101.22K | -50.49%44.55K | -45.94%49.09K | 19.50%-129.89K | 181.89%137.48K | ---148.49K | 57.04%89.97K | 258.48%90.79K |
| -Change in payables and accrued expense | 46.79%-31.63K | 52.35%16.27K | 61.19%-48.83K | 131.43%8.27K | 48.19%-8.33K | 61.92%-59.45K | -85.31%10.68K | -159.29%-125.8K | -121.42%-26.3K | -124.18%-16.07K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%190.61K | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 29.77%-209.31K | 20.14%-78.67K | 60.53%-464.86K | 89.07%-26.24K | 81.12%-42.11K | 52.96%-298.01K | -21.15%-98.5K | -59.10%-1.18M | 35.79%-239.94K | 2.43%-223.01K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 0 | 242.67%3M | 1 | 0 | ||||
| Net common stock issuance | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 242.67%3M | --1 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 242.67%3M | --1 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -25.37%1.25M | -24.06%1.36M | 898.49%1.8M | -32.23%1.36M | -39.55%1.43M | -45.93%1.68M | 898.49%1.8M | 296.21%179.83K | 262.98%2.01M | 240.88%2.37M |
| Current changes in cash | 29.76%-209.31K | 20.14%-78.67K | -125.55%-464.86K | 89.07%-26.24K | 81.12%-42.11K | 53.72%-298.01K | -103.37%-98.5K | 1,253.40%1.82M | 35.79%-239.94K | -56.79%-223.01K |
| Effect of exchange rate changes | -122.78%-12.14K | -72.57%-32.25K | 116.10%32.8K | 6.99%28.34K | 78.40%-30.13K | 160.00%53.28K | -858.36%-18.69K | ---203.78K | --26.49K | ---139.51K |
| End cash Position | -28.07%1.03M | -25.37%1.25M | -24.06%1.36M | -24.06%1.36M | -32.23%1.36M | -39.55%1.43M | -45.93%1.68M | 898.49%1.8M | 898.49%1.8M | 262.98%2.01M |
| Free cash from | 29.77%-209.31K | 20.14%-78.67K | 60.53%-464.86K | 89.07%-26.24K | 81.12%-42.11K | 52.96%-298.01K | -21.15%-98.5K | -59.10%-1.18M | 35.79%-239.94K | 2.43%-223.01K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data